Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced

Bionano Genomics, Inc. (BNGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 8-K Quarterly results
08/14/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer"
08/09/2023 8-K Quarterly results
Docs: "Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress"
08/04/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Bionano Genomics, Inc",
"Certificate of Elimination of Series A Preferred Stock"
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 8-K Quarterly results
Docs: "Bionano Reports First Quarter 2023 Results and Highlights Recent Business Progress"
04/24/2023 8-K Quarterly results
04/14/2023 8-K Quarterly results
03/13/2023 8-K Other Events  Interactive Data
03/09/2023 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Full Year 2022 Results and Provides Revenue Outlook for 2023"
02/03/2023 8-K Results of Operations and Financial Condition, Other Events  Interactive Data
01/05/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2022 Results - Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021"
11/30/2022 8-K Quarterly results
11/29/2022 8-K Quarterly results
11/28/2022 8-K Quarterly results
11/18/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
Docs: "Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022"
02/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2021 Results"
12/30/2021 8-K Entry into a Material Definitive Agreement  Interactive Data
12/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/04/2021 8-K Quarterly results
Docs: "Bionano Genomics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Progress",
"Q3 Webcast and Call November 4, 2021 2 Legal Disclaimer This"
10/19/2021 8-K Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits  Interactive Data
Docs: "Capitalization, Etc. 24 2.6 Financial Statements 26 2.7 Absence of Certain Changes 27 2.8 Title to and Condition of Assets 27 2.9 Real Property; Leasehold 27 2.10 Intellectual Property 28 2.11 Regulatory Matters 33 2.12 Material Contracts 36 2.13 Liabilities 38 2.14 Compliance with Laws; Export Controls 38 2.15 Certain Business Practices 39 2.16 Tax Matters 40 2.17 Employee Benefit Plans and Employee Matters 42 2.18 Environmental Matters 46 2.19 Insurance 46 2.20 Legal Proceedings; Orders 47 2.21 Non-Contravention; Consents 47 2.22 Financial Advisor 47 2.23 Related Party Transactions 47 2.24 [Reserved] 47 2.25 Customers and Suppliers 47 2.26 Takeover Statutes 48 2.27 Bank Accounts, Books and Records 48 2.28 HSR Act 48 2.29 Warranty Matters 48 2.30 Accounts Receivable 49 2.31 Reliance 49 SE..."
10/12/2021 8-K Acquisition/merger/asset purchase announced
Docs: "Bionano Genomics, Inc. 2020 Inducement Plan dated August 20, 2020, as amended",
"Bionano Genomics to Acquire BioDiscovery, Furthering Bionano’s Vision of Creating the Most Comprehensive Variant Analysis Platform in Genomics",
"Investor Presentation"
08/04/2021 8-K Quarterly results
Docs: "Bionano Genomics Reports Second Quarter 2021 Financial Results and Highlights Recent Business Progress",
"ADDED EXPERIENCED TALENT TO MANAGEMENT TEAM NEW GLOBAL REGIONS"
06/11/2021 8-K Quarterly results
05/14/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/24/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy